Atlanta 2/19/2013 8:23:27 AM
Helix BioPharma Corp. (Stock Symbol: TOR: CA:HBP) is now on LinkMyStock.com
Helix BioPharma Corp. has joined LinkMyStock.com. Now Stock Brokers, Brokerage Firms and Investors/Shareholders from around the world who follow Helix BioPharma Corp. can link directly to Helix BioPharma Corp. Link My Stock Hub. Brokers and Brokerage Firms that link to Helix BioPharma Corp. typically are familiar with the company and can facilitate transactions in Helix BioPharma Corp. security. Investors linking to Helix BioPharma Corp. usually are either existing shareholders looking to stay informed when Helix BioPharma Corp. posts new information or people that are simply interested in Helix BioPharma Corp. that are not yet or may never become shareholders.
LinkMyStock is a premier financial networking platform designed specifically for public companies, brokerage firms, brokers and investors. LinkMyStock.com provides a network that consists of brokers, brokerage firms and investors that can link directly to the companies that they follow. With brokers from around the world having the ability to select companies to link to that are members of Link My Stock this provides investors with the ability to locate brokers and contact them to find out more information about a company they are interested in learning more about.
LinkMyStock.com provides every member with their own hub where they post content. Content sections include; press releases, blogs, pictures, videos, Right Now status updates, events, jobs and more in order to attract more visitors and increase the number of search results along with improving indexing.
To link to the Helix BioPharma Corp. 's Link My Stock Hub sign into your Link My Stock Hub or Join Link My Stock today.
About Helix BioPharma Corp.
Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. Helix is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its novel L-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is currently listed on the TSX and FSE under the symbol "HBP."
